Regenerative Medicine Market Scenario
Rising investments in regenerative medicine research, technological advancements in the field of regenerative medicine and rising geriatric population are some of the major factors propelling the regenerative medicine market globally. Furthermore, increasing prevalence of chronic diseases, genetic disorders, and cancer is also one of the factor propelling the growth of regenerative medicine market. However, high cost cell and gene therapies is one of the major factor expected to hamper the global growth of the market.
Regenerative Medicine Market Segmentation
The regenerative medicine market is segmented by product, application and geography. The products studied in the regenerative medicine market are tissue-engineered products, cell therapies (autologous therapies and allogenic therapies), gene therapies and progenitor & stem cell therapies. Furthermore, various applications of regenerative medicine are musculoskeletal, oncology, wound care, dental, ocular and other applications. Based on Geography, the regenerative medicine market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
Regenerative Medicine Market by Geography
Based on geography, the regenerative medicine market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global regenerative medicine market. Major drivers include rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy. Moreover, rising prevalence of cancer in this region is also expected to support the growth of the market.
Regenerative Medicine Market Key Players
Some of the major players operating in the global regenerative medicine market includes 3M Group, AbbVie, Amgen, Inc., Integra Lifesciences Holdings Corporation, Medipost Co., Ltd., Medtronic Plc, Mimedx Group, Misonix, Novartis AG, Organogenesis Inc., Smith & Nephew Plc, Stryker Corporation, Takeda Pharmaceutical Company Limited, Vericel Corporation and Zimmer Biomet. Many companies in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market.
Regenerative Medicine Market Report Key Benefits